Moving on With Monoamine Oxidase Inhibitors.
Bodkin JA, Dunlop BW.
europepmc +1 more source
Study examining the inhibition of human monoamine oxidase (MAO) by the new psychoactive substance 5-(2-aminopropyl)indole (5-IT). Annex 2 to the “5-(2-Aminopropyl)indole (5-IT): Report on the risk assessment of 5-(2-aminopropyl)indole in the framework of the Council Decision on new psychoactive substances”. [PDF]
This report forms the basis for a risk assessment, which is convened by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) under auspices of its Scientific Committee and other externally invited experts.
Brandt, SD, Herraiz, T
core
The discovery of monoamine oxidase inhibitors: virtual screening and in vitro inhibition potencies. [PDF]
Shaw M +4 more
europepmc +1 more source
Monoamine Oxidase Inhibitors in Toxic Models of Parkinsonism. [PDF]
Buneeva O, Medvedev A.
europepmc +1 more source
Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in "Magic" Mushrooms. [PDF]
Blei F +8 more
europepmc +1 more source
Design, Synthesis, Biological Evaluation, and In Silico Study of Tetrahydropyridines as Prospective Monoamine Oxidase Inhibitors. [PDF]
Khan OUR +10 more
europepmc +1 more source
Monoamine Oxidase Inhibitors Present in Tobacco Modulate Dopamine Balance Via the Dopamine Transporter. [PDF]
Saro G +6 more
europepmc +1 more source
Synthesis of 1,2,4-Oxadiazin-5(6H)-One Derivatives and Their Biological Investigation as Monoamine Oxidase Inhibitors. [PDF]
Presnukhina SI +13 more
europepmc +1 more source
Design, Synthesis, and Biological Effect Studies of Novel Benzofuran-Thiazolylhydrazone Derivatives as Monoamine Oxidase Inhibitors. [PDF]
Osmani Ye D +9 more
europepmc +1 more source

